286 related articles for article (PubMed ID: 3472899)
1. The ocular pharmacokinetics of eicosanoids and their derivatives. 1. Comparison of ocular eicosanoid penetration and distribution following the topical application of PGF2 alpha, PGF2 alpha-1-methyl ester, and PGF2 alpha-1-isopropyl ester.
Bito LZ; Baroody RA
Exp Eye Res; 1987 Feb; 44(2):217-26. PubMed ID: 3472899
[TBL] [Abstract][Full Text] [Related]
2. Lack of prostaglandin F2 alpha metabolism by human ocular tissues.
Cheng-Bennett A; Poyer J; Weinkam RJ; Woodward DF
Invest Ophthalmol Vis Sci; 1990 Jul; 31(7):1389-93. PubMed ID: 2365570
[TBL] [Abstract][Full Text] [Related]
3. The penetration of exogenous prostaglandin and arachidonic acid into, and their distribution within, the mammalian eye.
Bito LZ; Baroody RA
Curr Eye Res; 1981-1982; 1(11):659-69. PubMed ID: 7346237
[TBL] [Abstract][Full Text] [Related]
4. In-vivo activity and enzymatic hydrolysis of novel prostaglandin F2 alpha prodrugs in ocular tissues.
Woodward DF; Chan MF; Cheng-Bennett A; Wheeler LA; Chen G; Burke JA; Kharlamb A; Lai RK; Shan T
Exp Eye Res; 1996 Oct; 63(4):411-23. PubMed ID: 8944548
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin F2 alpha isopropyl ester versus iloprost phenacyl ester in rabbit and beagle eyes.
Groeneboer MC; Hoyng PF; Kuizenga A
Curr Eye Res; 1989 Feb; 8(2):131-8. PubMed ID: 2540937
[TBL] [Abstract][Full Text] [Related]
6. Eicosanoids as a new class of ocular hypotensive agents. 3. Prostaglandin A2-1-isopropyl ester is the most potent reported hypotensive agent on feline eyes.
Bito LZ; Miranda OC; Tendler MR; Resul B
Exp Eye Res; 1990 Apr; 50(4):419-28. PubMed ID: 2338124
[TBL] [Abstract][Full Text] [Related]
7. The role of prostaglandins E2 and F2 alpha in ultraviolet radiation-induced cortical cataracts in vivo.
Andley UP; Fritz C; Morrison AR; Becker B
Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1539-48. PubMed ID: 8675396
[TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics of a new antiglaucoma drug, latanoprost, in the rabbit.
Sjöquist B; Basu S; Byding P; Bergh K; Stjernschantz J
Drug Metab Dispos; 1998 Aug; 26(8):745-54. PubMed ID: 9698288
[TBL] [Abstract][Full Text] [Related]
9. Transient loss of prostaglandin synthetic capacity in rabbit iris-ciliary body following anterior chamber paracentesis.
Graff G; Brady MT; Gamache DA; Spellman JM; Yanni JM
Ocul Immunol Inflamm; 1998 Dec; 6(4):227-38. PubMed ID: 9924919
[TBL] [Abstract][Full Text] [Related]
10. The effect of topical PGF2 alpha on uveoscleral outflow and outflow facility in the rabbit eye.
Poyer JF; Gabelt B; Kaufman PL
Exp Eye Res; 1992 Feb; 54(2):277-83. PubMed ID: 1559555
[TBL] [Abstract][Full Text] [Related]
11. The effects of prostaglandins on the blood-ocular barrier.
Kosaka T; Mishima HK; Kiuchi Y; Kataoka K
Jpn J Ophthalmol; 1995; 39(4):368-76. PubMed ID: 8926644
[TBL] [Abstract][Full Text] [Related]
12. Ocular disposition of topically applied histamine, cimetidine, and pyrilamine in the albino rabbit.
Hui HW; Zeleznick L; Robinson JR
Curr Eye Res; 1984 Feb; 3(2):321-30. PubMed ID: 6705556
[TBL] [Abstract][Full Text] [Related]
13. Multiple dosing of prostaglandin F2 alpha or epinephrine on cynomolgus monkey eyes. II. Slit-lamp biomicroscopy, aqueous humor analysis, and fluorescein angiography.
Camras CB; Bhuyan KC; Podos SM; Bhuyan DK; Master RW
Invest Ophthalmol Vis Sci; 1987 Jun; 28(6):921-6. PubMed ID: 3473055
[TBL] [Abstract][Full Text] [Related]
14. Eicosanoids as a new class of ocular hypotensive agents. 2. Comparison of the apparent mechanism of the ocular hypotensive effects of A and F type prostaglandins.
Hayashi M; Yablonski ME; Bito LZ
Invest Ophthalmol Vis Sci; 1987 Oct; 28(10):1639-43. PubMed ID: 3654137
[TBL] [Abstract][Full Text] [Related]
15. [Ocular penetration of UF-021, a new prostaglandin related compound, in the rabbit eye].
Watanabe C; Matsumoto S; Kin K; Tsuchisaka H; Ueno R
Nippon Ganka Gakkai Zasshi; 1992 Mar; 96(3):335-9. PubMed ID: 1580216
[TBL] [Abstract][Full Text] [Related]
16. The ocular effects of prostaglandins and the therapeutic potential of a new PGF2 alpha analog, PhXA41 (latanoprost), for glaucoma management.
Bito LZ; Stjernschantz J; Resul B; Miranda OC; Basu S
J Lipid Mediat; 1993; 6(1-3):535-43. PubMed ID: 8358014
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of latanoprost in the cynomolgus monkey. 3rd communication: tissue distribution after topical administration on the eye studied by whole body autoradiography. Glaucoma Research Laboratories.
Sjöquist B; Johansson A; Stjernschantz J
Arzneimittelforschung; 1999 Mar; 49(3):240-9. PubMed ID: 10219468
[TBL] [Abstract][Full Text] [Related]
18. Corneal permeability to and ocular metabolism of phenyl substituted prostaglandin esters in vitro.
Basu S; Sjöquist B; Stjernschantz J; Resul B
Prostaglandins Leukot Essent Fatty Acids; 1994 Apr; 50(4):161-8. PubMed ID: 8022849
[TBL] [Abstract][Full Text] [Related]
19. [The effects of long-term topically applied prostaglandins on aqueous protein concentration and the rabbit ciliary process].
Kosaka T
Nippon Ganka Gakkai Zasshi; 1994 May; 98(5):435-42. PubMed ID: 8197912
[TBL] [Abstract][Full Text] [Related]
20. Intraocular penetration of topical clindamycin in rabbits.
Mercer KB; DeOlden JE; Leopoid IH
Arch Ophthalmol; 1978 May; 96(5):880-4. PubMed ID: 655926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
